Physician profile
Gina C Davis
NPI 1669474631
$14,200.32
in general payments reported to CMS, 2019-2025
69 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,305 · 2022: $4,941 · 2023: $3,414 · 2024: $3,065 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,869 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,869.34 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,577.15 | 2021-2025 | |
| Mdd US Operations, LLC | $1,056.02 | 2022-2025 | Apokyn, Apokyn |
| Jazz Pharmaceuticals INC. | $1,019.20 | 2021-2024 | |
| Ucb, INC. | $1,000.93 | 2021-2024 | Briviact, Rystiggo, Nayzilam |
| Biogen, INC. | $999.47 | 2021-2024 | Vumerity, Tysabri, Avonex |
| Novartis Pharmaceuticals Corporation | $855.05 | 2021-2025 | |
| Eisai INC. | $795.58 | 2021-2024 | |
| Lilly USA, LLC | $508.24 | 2021-2024 | Emgality, Amyvid, Reyvow |
| Neurocrine Biosciences, INC. | $432.22 | 2021-2024 | Ingrezza, Ongentys |
| Alnylam Pharmaceuticals INC. | $417.57 | 2021-2024 | Onpattro |
| Vanda Pharmaceuticals INC. | $318.76 | 2022-2023 | Fanapt, Hetlioz |
| Teva Pharmaceuticals USA, INC. | $315.66 | 2021-2024 | Austedo Xr, Austedo |
| Catalyst Pharmaceuticals, INC. | $286.47 | 2021-2024 | Firdapse, Fycompa |
| Amgen INC. | $255.54 | 2021-2024 | Aimovig |
| Sunovion Pharmaceuticals INC. | $249.86 | 2021-2022 |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $226.92 | 2021-2024 | |
| Harmony Biosciences LLC | $208.51 | 2022-2024 | Wakix |
| Biohaven Pharmaceutical Holding Company LTD. | $207.86 | 2022 | |
| Amneal Pharmaceuticals LLC | $196.12 | 2021-2024 | Rytary |
| Alexion Pharmaceuticals, INC. | $193.89 | 2021-2024 | Ultomiris, Soliris |
| Emd Serono, INC. | $191.51 | 2021-2023 | Mavenclad |
| Tg Therapeutics, INC. | $164.61 | 2023-2024 | |
| Lundbeck LLC | $154.71 | 2021-2024 | Vyepti |
| Neurelis, INC. | $148.43 | 2021-2023 | Valtoco |
| Celgene Corporation | $147.46 | 2021-2024 | Zeposia |
| Kyowa Kirin, INC. | $135.09 | 2021-2024 | Nourianz |
| Banner Life Sciences, LLC | $134.28 | 2022-2024 | |
| Acorda Therapeutics, INC | $124.19 | 2021-2023 | Inbrija, Ampyra |
| Mallinckrodt Hospital Products INC. | $121.65 | 2022 | |
| Greenwich Biosciences, INC. | $95.55 | 2021 | |
| Acadia Pharmaceuticals INC | $94.52 | 2021-2024 | Nuplazid |
| Argenx US, INC. | $92.41 | 2022-2023 | Vyvgart |
| Genentech USA, INC. | $88.61 | 2022-2024 | Ocrevus |
| Avanir Pharmaceuticals, INC. | $87.28 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $81.25 | 2021-2023 | |
| Genzyme Corporation | $81.14 | 2021-2023 | |
| Livanova USA, INC. | $77.92 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceuticals, INC. | $74.72 | 2021 | |
| Dexcom, INC. | $67.07 | 2024-2025 | Dexcom G6 Transmitter |
| Grifols USA, LLC | $63.05 | 2023-2024 | Gamunex-C |
| Horizon Therapeutics Plc | $62.38 | 2022-2023 | Uplizna |
| Pfizer INC. | $60.39 | 2024 | |
| Allergan, INC. | $58.05 | 2021-2022 | |
| Tanabe Pharma America, INC. | $51.94 | 2021-2023 | |
| Cala Health, INC. | $50.82 | 2024-2025 | Cala Kiq, Cala Kiq, Cala Trio |
| Idorsia Pharmaceuticals US INC | $45.91 | 2022-2023 | Quviviq |
| Avion Pharmaceuticals | $40.50 | 2022-2023 | Dhivy |
| Supernus Pharmaceuticals, INC. | $39.10 | 2021 | |
| Exact Sciences Corporation | $30.80 | 2025 | The Cologuard Plus Collection Kit |
| Adamas Pharmaceuticals, INC. | $30.36 | 2021 | |
| Medtronic, INC. | $28.37 | 2022 | |
| Almatica Pharma LLC | $27.98 | 2021 | |
| Ani Pharmaceuticals, INC. | $26.73 | 2023 | Purified Cortrophin Gel |
| Avadel Cns Pharmaceuticals, LLC | $26.49 | 2024 | Lumryz |
| Octapharma USA, INC. | $25.75 | 2024 | Octagam Immune Globulin (Human) |
| Sumitomo Pharma America, INC. | $25.17 | 2023 | Brovana |
| Microtransponder, INC. | $24.88 | 2024 | |
| Sanofi-Aventis U.S. LLC | $23.11 | 2021 | |
| Inspire Medical Systems, INC. | $21.98 | 2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $19.01 | 2024 | Hyqvia |
| Boston Scientific Corporation | $18.84 | 2024 | Watchman Flx |
| Scilex Pharmaceuticals INC. | $17.23 | 2024 | |
| Janssen Pharmaceuticals, INC | $16.21 | 2024 | Spravato |
| Abbott Laboratories | $15.87 | 2024 | Infinity |
| Collegium Pharmaceutical, INC. | $15.75 | 2022 | |
| Aprecia Pharmaceuticals, LLC | $14.22 | 2022 | |
| Hologic Sales and Service, LLC | $13.86 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.27 | 2024 | |
| Corium, LLC | $8.88 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gina Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.